TipRanks on MSN
GenFleet Therapeutics launches pioneering Phase III study for pancreatic cancer treatment
Genfleet Therapeutics (Shanghai), Inc. Class H ( ($HK:2595) ) just unveiled an announcement. GenFleet Therapeutics has initiated the first ...
New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.
HOUSTON, DECEMBER 4, 2025 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...
Researchers at The University of Texas MD Anderson Cancer Center have identified a specific protein, RASH3D19, that is ...
More than 20,000 girls and women are now registered to play football in Wales, marking a major milestone for the Football Association of Wales.
Researchers at The University of Texas MD Anderson Cancer Center have identified a specific protein, RASH3D19, that is ...
Summary • Erasca, Inc. (ERAS) shares rose 14.1% to $3.30 amid conference participation.• The company is attending the Evercore Healthcare Conference to discuss RAS/MAPK therapy advancements.• Analysts ...
Robert Rose, CEO and co-founder of Reliable Robotics, the leader in autonomous aircraft systems, today delivered testimony ...
Under the updated rules, graduates from any discipline can now apply to become IAs or RAs. Until now, only candidates with ...
A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d'Oncologia (ICO) has ...
Summary • BridgeBio Oncology Therapeutics (BBOT) rises 17.7% in pre-market trading, reaching $14.49 from $12.31.• The increase follows the announcement of leadership participation in upcoming investor ...
Global technology leader and cross-border innovation strategist Sundeep Kumar Makthala has been awarded a Palace-Endorsed UAE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results